tiprankstipranks
Guardion Health Sciences Announces Delisting and New Interim CEO
Company Announcements

Guardion Health Sciences Announces Delisting and New Interim CEO

Guardion Health Sciences ( (GHSI) ) has issued an announcement.

Don't Miss our Black Friday Offers:

Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, announcing both the delisting of its common stock from the Nasdaq Capital Market and the appointment of Mark Goldstone as the Interim President and CEO, effective October 18, 2024. This move comes as part of a larger dissolution and liquidation plan following the sale of its Viactiv® brand. Goldstone, with over two decades of healthcare industry experience, takes over from Janet Hall and will be compensated $7,500 monthly for his new roles. As the company prepares for its dissolution, it plans to pay a liquidating dividend to its shareholders, with the exact amount and timing subject to various factors, including the resolution of its liabilities and the sale of remaining assets.

See more insights into GHSI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyGuardion Health Sciences announces adoption of plan of dissolution, liquidation
TipRanks Auto-Generated NewsdeskGuardion Health Sciences CEO Jan Hall Set to Depart
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App